Aptorum Group Limited (NASDAQ:APM) Short Interest Down 58.4% in April

Aptorum Group Limited (NASDAQ:APM) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 41,000 shares, a drop of 58.4% from the March 31st total of 98,500 shares. Currently, 1.9% of the shares of the stock are short sold. Based on an average daily volume of 2,340,000 shares, the short-interest ratio is currently 0.0 days.

Aptorum Group Stock Down 1.4 %

APM stock opened at $5.48 on Friday. The business has a 50-day simple moving average of $6.18 and a 200 day simple moving average of $3.34. Aptorum Group has a 52 week low of $1.35 and a 52 week high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.